ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

Einhorn Sees More Results Coming Similar to Big Successes in Testicular Cancer

May 15, 1981

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007

Drugs Available To Investigators Centers to Monitor Them Are Listed

September 9, 1977